Flexion Therapeutics Inc

NASDAQ:FLXN   3:59:58 PM EDT
11.35
+0.64 (+5.98%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)559.55M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$25.66 Million
Adjusted EPS-$0.45
See more estimates
10-Day MA$11.14
50-Day MA$11.55
200-Day MA$11.46
See more pivots

Flexion Therapeutics Inc Stock, NASDAQ:FLXN

10 MALL ROAD, SUITE 301, BURLINGTON, MA 01803
United States of America
Phone: (781) 305-7777
Number of Employees: 272

Description

Flexion Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It lead product candidate includes Zilretta, a late-stage, intra-articular, extended-release investigational steroid treatment that has completed Phase 3 clinical trials for IA therapy for patients with moderate and severe osteoarthritis pain. The company was founded in 2007 and is headquartered in Burlington, Massachusetts.